STAT November 12, 2024
Ed Silverman

J&J argues the U.S. Health Resources and Services Administration wrongfully interpreted federal law

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some hospitals that participate in a federal drug discount program.

In its lawsuit, the company argued the U.S. Health Resources...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Putting Patients First by Extending the Reach of World-Class Care
Biotech startups are built on venture capital. Track funding rounds here.

Share This Article